Brynn Marks

Has grant

Attending Physician in Pediatric Endocrinology, Director of Technology of the Diabetes Center, Assistant Professor of Pediatrics

Children's Hospital of Philadelphia

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Type 1 Diabetes Exchange Quality Improvement Collaborative

Open Date: 2021-05-01

Close Date: 2023-04-01

Grant: Close

Use of a Hybrid Closed Loop Insulin Delivery System in a High Risk Type 1 Diabetes Population

Open Date: 2021-03-01

Close Date: 2022-06-01

Grant: Close

Correlations between CGM and Serum Glucose During OGTT Testing for CFRD

Open Date: 2021-01-01

Close Date: 2022-12-01

Grant: Close

EnVision CF: Emerging Leaders in CF Endocrinology

Open Date: 2019-09-01

Close Date: 2023-03-01

Grant: Close

Rising Star Award

Open Date: 2018-03-01

Close Date: 2019-03-01

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Elizabeth Mann

Assistant Professor

University of Wisconsin School of Medicine and Public Health

UNITED STATES

View details

Rebecca Hicks

HS Assistant Clinical Professor

University of California, Los Angeles

UNITED STATES

View details

Erin Janssen

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Brynn Marks

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (16)

The Type of Patient Training Does Not Impact Outcomes in the First 90 Days of Automated Insulin Delivery Use

Hybrid Closed Loop Systems Improve Glycemic Control and Quality of Life in Historically Minoritized Youth with Diabetes

ROUTE-T1D: A behavioral intervention to promote optimal continuous glucose monitor use among racially minoritized youth with type 1 diabetes: Design and development

Virtual Learning and Youth-Onset Type 2 Diabetes during the COVID-19 Pandemic

Differences in positive expectancy of hybrid closed loop (HCL) insulin delivery systems do not explain racial differences in HCL use

Applying the use of shared medical appointments (SMAs) to improve continuous glucose monitor (CGM) use, glycemic control, and quality of life in marginalized youth with type 1 diabetes: Study protocol for a pilot prospective cohort study

Baseline Quality Improvement Capacity of 33 Endocrinology Centers Participating in the T1D Exchange Quality Improvement Collaborative

Real-World Glycemic Outcomes with Early Omnipod 5 Use in Youth with Type 1 Diabetes

Case Report: Insulin hypersensitivity in youth with type 1 diabetes

Preferences for Health Care Professional Interactions Among Adolescents and Young Adults with Type 1 Diabetes

Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systems.

Cystic fibrosis-related diabetes: The patient perspective.

Spontaneous and iatrogenic hypoglycemia in cystic fibrosis.

Increase in the Diagnosis and Severity of Presentation of Pediatric Type 1 and Type 2 Diabetes during the COVID-19 Pandemic.

Juvenile Granulosa Cell Tumor as the Presenting Feature of McCune-Albright Syndrome

Patterns of continuous glucose monitoring use in young children throughout the first 18-months following T1D diagnosis.

Collaborators (3)

Elizabeth Mann

Rebecca Hicks

Erin Janssen

Make your next move.